All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Stefano Schena, MD, PhD
Jessica Rove, MD

Panelists

Moritz C. Wyler von Ballmoos, MD, PhD, MPH
Disclosure(s): Boston Scientific Corp: Advisory Board (Ongoing), Consultant (Ongoing)

Presentations

1. Long-Term Outcomes Following Early Discontinuation of Oral Anticoagulation After Left Atrial Appendage Ligation in Patients with Atrial Fibrillation
   Nicholas J. Goel, MD
    
2. Robotic Ablation and LAA Management
   Arman Arghami, MD, MPH
    
3. Left Atrium or Two Atrial Ablation and a Clip: What Should be the Aim When Surgically Addressing AF?
   Ralph Damiano, Jr., MD
   Disclosure(s): Atricure: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards: Advisory Board (Ongoing), Speaker (Ongoing); Medtronic: Consultant (Ongoing), Speaker (Ongoing); Pulse Biosciences: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
    
4. You Have Done a Surgical Ablation, But Did It Actually Work? The Importance of Follow Up: Longitudinal Outcomes/Follow Up
   Armin Kiankhooy, MD
    
5. Do Current Surgical AF Trials Focus on the Left Appendage Only?
   HelenMari Merritt, DO
   Disclosure(s): AtriCure,: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
    
6. Panel Discussion